SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-065618
Filing Date
2020-05-26
Accepted
2020-05-26 07:04:56
Documents
2
Effectiveness Date
2020-05-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2020903d1_defa14a.htm DEFA14A 34512
2 GRAPHIC tm2020903d1_defa14aimg001.jpg GRAPHIC 6650
  Complete submission text file 0001104659-20-065618.txt   44825
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37635 | Film No.: 20908089
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences